Singapore and Japan Clinician-Scientists Collaborate on Groundbreaking Telesurgery Trial Spanning over 5,000km

25 Apr 2022

A friend, not foe: Parasite in gastrointestinal system found to promote health

A study conducted by researchers from the NUS Yong Loo Lin School of Medicine demonstrated that a gut parasite suppresses inflammation and improves the health of the gastrointestinal system.

19 Apr 2022

Particles released by red blood cells are effective carriers for anti-cancer immunotherapy: Singapore study

A study demonstrated that vesicles released by red blood cells are a viable platform for delivering immunotherapeutic RNA molecules to suppress breast cancer growth and metastasis.

13 Apr 2022

Myopericarditis risk after COVID-19 vaccination is low, according to international study

An international study published in The Lancet Respiratory Medicine found that the overall risk of myopericarditis, or heart inflammation, following COVID-19 vaccination is very low, affecting only 18 people per million vaccine doses.

30 Mar 2022

Medical students demonstrate efficacy of COVID-19 vaccines in multiple immunocompromised patient groups

The student researchers from NUS Medicine published a systematic review and meta-analysis of the efficacy of COVID-19 vaccines in multiple immunocompromised patient groups in The BMJ, one of the foremost peer-reviewed medical journals available. This recognition from veteran researchers in their field was a significant achievement for the students.

28 Mar 2022

NUS-Monash University collaboration produces universal flu vaccine candidate

Researchers from the NUS Medicine and Monash University have successfully leveraged on a novel vaccine platform to prove that a single shot immunisation containing the M2e peptide was able to trigger long-lasting immune responses that could protect effectively against multiple strains of the flu.

23 Mar 2022

NUS Medicine Launches Philip Yeo Professorship in Medicine

NUS Medicine establishes a new professorship in honour of Mr Philip Yeo, one of Singapore’s best-known public service leaders.

18 Mar 2022

Genetic Ancestry Matters in Childhood Leukemia Treatment Success

Researchers from the NUS Yong Loo Lin School of Medicine and St Jude Children's Research Hospital in the USA have shown that it is important to consider race and genetic ancestry in treating acute lymphoblastic leukemia (ALL) in children.

08 Mar 2022

NUS Yong Loo Lin School of Medicine students and researchers develop novel algorithm to assess immunotherapy benefit in stomach cancer patients

A group of students and researchers from Yong Loo Lin School of Medicine created a novel algorithm to identify patients who would not benefit from joint immunotherapy-chemotherapy treatment.

08 Feb 2022

Harvesting baker's yeast for ageing-related therapeutics

Researchers from Singapore and the UK successfully engineer common baker's yeast to produce D-lysergic acid (DLA), an ingredient used in medicine for dementia and Parkinson's Disease.

08 Feb 2022

NUS Medicine cardiovascular research team develops anticoagulant drugs with high anticlotting efficacy and minimal bleeding

A team lead by Research Assistant Professor Koh Cho Yeow from the Cardiovascular Diseases Translational Research Programme at Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Cardiovascular Research Institute, Associate Professor Mark Chan, from the Department of Medicine, NUS Medicine, who is also the Deputy Director (Clinical Research Matters) from the Cardiovascular Research Institute and National University Heart Centre, as well as, Professor R. Manjunatha Kini from the Department of Biological Sciences at NUS, developed a series of thrombin inhibitors to be powerful anticoagulants, commonly known as blood thinners or anticlotting medications.